A highly regulated industry
deserves AI built to match it.
Pharmaceutical and medical device teams operate where compliance failures have real consequences. Leah gives legal, regulatory, and commercial teams one AI platform built for exactly this environment — audit-ready, regulation-aware, and built to scale.
Pharma moves fast. Manual processes hold it back.
Contract volumes grow. Regulations tighten. Audit expectations don't pause. Pharma organizations aren't failing — they're running lean teams against volumes, regulatory demands, and operational complexity that manual processes can't handle. Legacy systems create compliance gaps at the worst time. Every hour spent on administration is an hour not spent on the mission.
“We had an internal audit and we didn't pass because we didn't have versions of drafted documents that led to the final version. That's when we knew the process had to change completely.”
— Legal Counsel, Contract Development and Manufacturing OrganizationSix pressures every pharma and medical device team knows too well.
Regulatory compliance without audit trails
21 CFR Part 11 and GxP require complete traceability for every document and approval step. Email workflows and legacy systems fail to deliver the evidence trail FDA and EMA inspections require.
Volume growth outpacing legal capacity
Contract intake scales with the business — but legal teams can't keep pace. The result is a growing backlog that delays deals and forces teams to triage instead of operate strategically.
IP and licensing complexity at scale
Milestone triggers, exclusivity windows, and royalty terms must be monitored across the full portfolio. Manual tracking can't surface obligations before they're missed — and missed IP windows threaten commercial positions.
Clinical trial agreement complexity
CTAs involve multi-party obligations, site-specific terms, and milestone payments spanning years. Managing dozens of active sites simultaneously requires systematic tracking that manual processes can't reliably deliver.
Post-transaction integration chaos
Mergers, spinoffs, and carve-outs create portfolios scattered across legacy systems, requiring contract segregation, ownership reassignment, and governance restoration from day one.
Global operations without consistent governance
Operations across 50+ countries require consistent governance across different regulatory environments and languages. Without centralized contract intelligence, standards can't be enforced across the full global footprint.
The AI that works across every regulated workflow.
Agentic AI that executes work, maintains compliance, and monitors obligations across legal, regulatory, clinical, procurement, and commercial teams — simultaneously.
Make audit readiness the default — not the emergency.
Leah makes audit readiness the default state — not a scramble before inspection. Every version, approval step, and modification is preserved by design, so when regulators ask, the documentation is already there.
“We had an internal audit and we didn’t pass because we didn’t have versions of drafted documents that led to the final version. Leah is doing everything correctly — there’s nothing wrong with how it handles this. That’s the difference.”
— Legal Counsel, Contract Development and Manufacturing Organization
What changes when pharma teams can actually move?
Real outcomes from pharmaceutical and life sciences organizations managing the same regulatory complexity and operational scale.
Your role. Your outcomes.
Pharmaceutical complexity doesn't belong to one team. Neither does the solution.
Scale legal capacity without scaling headcount.
Pharmaceutical legal teams manage clinical agreements, licensing deals, quality contracts, and commercial work — across multiple countries simultaneously, with teams that can’t grow as fast as the pipeline. Leah moves the volume ceiling.
- Absorb volume growth without adding staff — AI reviews, redlines, and routes agreements against your playbooks; your lawyers engage only where judgment genuinely matters.
- Purpose-built for pharmaceutical legal work — AI trained on pharmaceutical contract language and structures; MSAs, licensing agreements, and clinical contracts understood with the precision the industry requires.
- Answer questions across the portfolio instantly — natural language queries surface change-of-control clauses, exclusivity terms, and IP provisions across thousands of agreements in seconds.
- Accelerate M&A diligence — acquired and target portfolios reviewed for material risks, IP provisions, and contractual liabilities in hours rather than weeks.
- Maintain audit readiness continuously — complete version histories, approval trails, and compliance documentation maintained without manual effort; 21 CFR Part 11 compliance by design.
“Every single legal term and clause matters in our MSAs and licensing agreements. Leah understands that — and the precision it delivers reflects it.”— Senior Director Business Operations, Oncology Biotech
Got Questions? Get Answers.
21 CFR Part 11 compliance is built into Leah’s architecture — not bolted on as an option. Electronic signatures are maintained to the standard FDA requires, with full version control preserving every draft, redline, and revision that led to the executed document. Every approval step is logged with timestamps and user attribution. GxP-compliant workflows ensure that the documentation standards clinical and quality operations require are maintained continuously — so when an FDA inspector asks to see the full history of a contract, it’s already there, organized, and defensible. Leah also supports formal system validation processes with staging and production environments for regulated deployment.
Post-transaction portfolio consolidation is one of Leah’s most established use cases in pharma. AI-powered extraction compresses migration timelines by 70% compared to manual approaches — processing contracts from multiple legacy systems simultaneously, extracting key data, and making the full portfolio searchable and queryable from day one. Entity segregation, access controls, and ownership reassignment for contracts previously held by departed employees are all handled systematically. Organizations that previously had no idea how many contracts they held — or what types — gain a complete, centralized view rapidly.
Clinical trial agreements and quality agreements are managed as living, monitored documents — not static files. Site-level obligations are tracked against agreed timelines across every active trial simultaneously. Quality provisions in CDMO and supplier agreements are monitored against performance, with audit rights, CAPA provisions, and certification currency surfaced automatically. The 10-year regulatory retention requirements common in life sciences are maintained systematically — documents remain accessible and compliant throughout the full retention window without manual tracking.
Multi-country pharmaceutical operations are a core deployment scenario for Leah — with production deployments supporting operations across 100+ countries and multiple languages. Each country or entity can have its own regulatory requirements, approval matrices, and access controls configured within one connected platform. Country-specific compliance obligations are mapped to applicable contracts and monitored continuously. The result is a single global view of the commercial and compliance position across all entities, without requiring separate systems or processes for each jurisdiction.
Yes — and some of the most enduring Leah partnerships in life sciences are with clinical-stage biotechs that have grown with the platform from early development through commercial operations. Lean legal teams at biotech organizations typically face the sharpest version of the volume-versus-capacity problem: a growing pipeline of clinical trial agreements, licensing deals, and quality obligations managed by a team that cannot scale at the same pace. Leah is designed to layer over existing systems without data migration or disruptive implementation, delivering measurable capacity relief quickly.
Enterprise integration with pharmaceutical technology stacks is a core capability. SAP and Ariba integration connects procurement workflows to contract intelligence. Veeva and quality management system integration connects quality agreement obligations to the systems clinical and quality operations teams already use. DocuSign integration supports electronic signature workflows. And Salesforce integration connects commercial deal flow to contract execution. API and middleware capabilities support custom integrations for pharma-specific platforms and legacy systems.
